YINKA JACKSON: Open Payments
NPI 1104470038 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,933 in 46 payments from 11 companies in 2025. Trend: 2023 $821 · 2024 $742 · 2025 $1,933
Food & beverage: $1,929Education: $4
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $552 |
| Teva Pharmaceuticals USA, Inc. | 11 | $517 |
| Alkermes, Inc. | 5 | $196 |
| Axsome Therapeutics, Inc. | 3 | $182 |
| Neurocrine BioSciences, Inc. | 2 | $145 |
| Supernus Pharmaceuticals, Inc. | 3 | $144 |
| Almatica Pharma LLC | 3 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 1 | $38 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
Products named: CAPLYTA, UZEDY, Auvelity, INGREZZA, Qelbree, LYBALVI, ARISTADA, LOREEV XR.
Industry payments across FL — which companies pay providers there.
